BioLineRx (BLRX) Exchange Rate Effect (2013 - 2025)
BioLineRx's (BLRX) quarterly Exchange Rate Effect came in at $125000.0 in Q4 2025, down 22.84% year-on-year from $162000.0 in Q4 2024, and up 68.92% quarter-over-quarter from $74000.0 in Q3 2025.
BioLineRx (BLRX) Exchange Rate Effect (2013 - 2025) Analysis & Trends
BioLineRx's Exchange Rate Effect history runs 13 years deep, the most recent figure standing at $125000.0 for Q4 2025.
- On a quarterly basis, Exchange Rate Effect fell 22.84% year-over-year to $125000.0 in Q4 2025; TTM through Dec 2025 was $549000.0, a 2395.45% increase from a year earlier, with the FY2025 full-year figure at $549000.0, up 2395.45% from the prior year.
- Exchange Rate Effect rose to $125000.0 in Q4 2025 per BLRX's latest filing, from $74000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $625000.0 in Q2 2022 and bottomed at -$1.1 million in Q3 2022.
- The 5-year median for Exchange Rate Effect is $500.0 (2022), against an average of -$2650.0.
- Across the five-year window, Exchange Rate Effect plunged 1621.54% in 2022 and surged 484.0% in 2023, its largest moves.
- Year by year, Exchange Rate Effect stood at $244000.0 in 2021, then sank by 120.49% to -$50000.0 in 2022, then jumped by 484.0% to $192000.0 in 2023, then declined by 15.62% to $162000.0 in 2024, then dropped by 22.84% to $125000.0 in 2025.
- Per Business Quant, the three latest BLRX Exchange Rate Effect figures stand at $125000.0 (Q4 2025), $74000.0 (Q3 2025), and $432000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | 125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 125,000.00 |
| Dec 31, 2025 | 125,000.00 |
| Sep 30, 2025 | 74,000.00 |
| Sep 30, 2025 | 74,000.00 |
| Jun 30, 2025 | 432,000.00 |
| Jun 30, 2025 | 432,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Sep 30, 2024 | -361,000.00 |
| Sep 30, 2024 | -361,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Sep 30, 2023 | -72,000.00 |
| Sep 30, 2023 | -72,000.00 |